Protodesnitazene

Pharmaceutical compound From Wikipedia, the free encyclopedia

Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia, the United Kingdom and Finland, first appearing in early 2025.[1][2][3][4][5][6][7][8]

CAS Number
Quick facts Identifiers, CAS Number ...
Protodesnitazene
Identifiers
  • N,N-diethyl-2-[2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H31N3O
Molar mass365.521 g·mol−1
3D model (JSmol)
  • CCCOC1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2CCN(CC)CC
  • InChI=1S/C23H31N3O/c1-4-17-27-20-13-11-19(12-14-20)18-23-24-21-9-7-8-10-22(21)26(23)16-15-25(5-2)6-3/h7-14H,4-6,15-18H2,1-3H3
  • Key:CEHFMRGBRNNSCM-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI